Illumina Inc. (NASDAQ: ILMN) is an American company that provides sequencing- and array-based solutions. The company’s products and services serve customers in various markets, supporting the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Illumina also offers instruments and consumables used in genetic analysis.
ILMN
Illumina Inc
NASDAQ
224.55
USD
-0.18%
-0.40
OPEN
223.09
PREV CLOSE
224.95
DAY RANGE
225.13 - 220.05
VOLUME
1.6M
AVG. VOLUME
1.7M
52 WEEK RANGE
371.16 - 173.45
Buy ILMN stocks now with Interactive Brokers – the most advanced investment platform
Valuations metrics
Market capitalization
35.5B
Enterprise value
37B
Forward pe
71.97116
Peg ratio
71.97116
Price to sales ttm
7.7534895
Price to book mrq
5.376383
Enterprise to revenue
8.071
Enterprise to ebitda
64.567
Financials
Fiscal year ends
2023-01-01
Most recent quarter
2023-01-01
Profit margin
-0.96072996
Operating margin
0.039049998
Return on assets ttm
0.00815
Return on equity ttm
-0.50799
Income statement
Revenue ttm
4.6B
Revenue per share ttm
29.197
Quarterly revenue growth
-0.097
Gross profit ttm
3.1B
Ebitda
617M
Net income to common ttm
-4403999744
Diluted eps ttm
-27.84
Quarterly earnings growth yoy
-0.09674728940784
Balance sheet
Total cash mrq
2B
Total cash per share mrq
12.892
Total debt mrq
3.6B
Total debt to equity mrq
53.872
Current ratio mrq
1.284
Book value per share mrq
41.766
Cash flow
Operating cash flow ttm
392M
Levered free cash flow ttm
666.6M
Stock statistics
Shares outstanding
158M
Float shares
157.7M
Avg 10 volume
1.7M
Avg 30 volume
1.5M
Shares short
4.3M
Short ratio
3.41
Short percent of shares outstanding
0.031600002
Percent held by insiders
0.00402
Percent held by institutions
0.93481004
Stock price summary
Fifty two week low
173.45
Fifty two week high
371.16
Fifty two week change
-54.531
Beta
1.145562
Day 50 ma
208.6578
Day 200 ma
207.8443
Dividends and splits
Last split factor
2-for-1 split
Last split date
2008-09-23